Is monocyte chemotactic protein 1 elevated in aseptic loosening of TKA?: A pilot study

Clinical Orthopaedics and Related Research

Volumn 470, Issue 7, 2012, Pages 1879-1884

  Dasa, Vinod ^a   Kramer, Jill M ^b   Gaffen, Sarah L ^d   Kirkwood, Keith L ^c   Mihalko, William M ^e,f  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f InMotion Orthopaedic Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYTICAL EQUIPMENT; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MALE; OSTEOLYSIS; PRIORITY JOURNAL; PROSTHESIS LOOSENING; REOPERATION; RHEUMATOID ARTHRITIS; SCREENING; SYNOVIAL FLUID; TOTAL KNEE REPLACEMENT;

EID: 84864278704     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-2191-5     Document Type: Conference Paper

References (42)

1. Andersson MK, Anissian L, Stark A, Bucht E, Felländer-Tsai L, Tsai JA. Synovial fluid from loose hip arthroplasties inhibits human osteoblasts. Clin Orthop Relat Res. 2000;378:148-154.
2. Beraudi A, Stea S, Cremonini S, Visentin M, Toni A. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty. Artif Organs. 2009;33: 538-543.
3. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344:907-916. (Pubitemid 32224400)
4. Clarke SA, Brooks RA, Hobby JL, Wimhurst JA, Myer BJ, Rushton N. Correlation of synovial fluid cytokine levels with histological and clinical parameters of primary and revision total hip and total knee replacements. Acta Orthop Scand. 2001;72: 491-498. (Pubitemid 33043589)
5. Engh GA, Ammeen DJ. Bone loss with revision total knee arthroplasty: defect classification and alternatives for reconstruction. Instr Course Lect. 1999;48:167-175.
6. Fritz EA, Glant TT, Vermes C, Jacobs JJ, Roebuck KA. Titanium particles induce the immediate early stress responsive chemokines IL-8 and MCP-1 in osteoblasts. J Orthop Res. 2002;20: 490-498. (Pubitemid 34461007)
7. Fritz EA, Glant TT, Vermes C, Jacobs JJ, Roebuck KA. Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. J Biomed Mater Res A. 2006;77:192-201.
8. Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep. 2000;2:459-465.
9. Goldring MB. Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther. 2001;1:817-829. (Pubitemid 33769741)
10. Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford). 2003;42(suppl 2): ii11-ii16. (Pubitemid 37220895)
11. Goodman SB, Ma T. Cellular chemotaxis induced by wear particles from joint replacements. Biomaterials. 2010;31:5045-5050.
12. Granchi D, Verri E, Ciapetti G, Stea S, Savarino L, Sudanese A, Mieti M, Rotini R, Dallari D, Zinghi G, Montanaro L. Boneresorbing cytokines in serum of patients with aseptic loosening of hip prostheses. J Bone Joint Surg Br. 1998;80:912-917. (Pubitemid 28457091)
13. Inomoto M, Miyakawa S, Mishima H, Ochiai N. Elevated interleukin-12 in pseudosynovial fluid in patients with aseptic loosening of hip prosthesis. J Orthop Sci. 2000;5:369-373. (Pubitemid 30662805)
14. Ishiguro N, Kojima T, Ito T, Saga S, Anma H, Kurokouchi K, Iwahori Y, Iwase T, Iwata H. Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res. 1997;35:399-406. (Pubitemid 27193931)
15. Jiranek WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, Harris WH. Production of cytokines around loosened cemented acetabular components: analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am. 1993;75:863-879. (Pubitemid 23206699)
16. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33-42.
17. Konttinen YT, Waris V, Xu JW, Jiranek WA, Sorsa T, Virtanen I, Santavirta S. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol. 1997;24:694-701. (Pubitemid 27146087)
18. Konttinen YT, Xu JW, Waris E, Li TF, Gómez-Barrena E, Nordsletten L, Santavirta S. Interleukin-6 in aseptic loosening of total hip replacement prostheses. Clin Exp Rheumatol. 2002;20: 485-490. (Pubitemid 34846622)
19. Koreny T, Tunyogi-Csapó M, Gál I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum. 2006;54:3221-3232. (Pubitemid 44622093)
20. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103:1345-1352. (Pubitemid 29218305)
21. Lassus J, Salo J, Jiranek WA, Santavirta S, Nevalainen J, Matucci-Cerinic M, Horák P, Konttinen Y. Macrophage activation results in bone resorption. Clin Orthop Relat Res. 1998;352:7-15. (Pubitemid 28326279)
22. Levinger I, Levinger P, Trenerry MK, Feller JA, Bartlett JR, Bergman N, McKenna MJ, Cameron-Smith D. Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthritis Rheum. 2011;63:1343-1348.
23. Mortazavi SM, Molligan J, Austin MS, Purtill JJ, Hozack WJ, Parvizi J. Failure following revision total knee arthroplasty: infection is the major cause. Int Orthop. 2011;35:1157-1164.
24. Nakashima Y, Sun DH, Trindade MC, Chun LE, Song Y, Goodman SB, Schurman DJ, Maloney WJ, Smith RL. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg Br. 1999;81:155-162. (Pubitemid 29043430)
25. O'Dell JR. Anticytokine therapy - a new era in the treatment of rheumatoid arthritis? N Engl J Med. 1999;340:310-312. (Pubitemid 29063276)
26. Rahimi P, Wang CY, Stashenko P, Lee SK, Lorenzo JA, Graves DT. Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse. Endocrinology. 1995;136:2752-2759.
27. Revell PA, Jellie SE. Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements. J Mater Sci Mater Med. 1998;9:727-730. (Pubitemid 29043278)
28. Rollins B. MCP-1, MCP-2, MCP-3, MCP-4 and MCP-5. In: Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicos NA, eds. Cytokine Reference. New York, NY: Academic Press; 2000:1145-1160.
29. Sabokbar A, Rushton N. Role of inflammatory mediators and adhesion molecules in the pathogenesis of aseptic loosening in total hip arthroplasties. J Arthroplasty. 1995;10:810-816. (Pubitemid 26003247)
30. Saeed S, Revell PA. Production and distribution of interleukin 15 and its receptors (IL-15Ralpha and IL-R2beta) in the implant interface tissues obtained during revision of failed total joint replacement. Int J Exp Pathol. 2001;82:201-209. (Pubitemid 32718500)
31. Saidenberg-Kermanac'h N, Cohen-Solal M, Bessis N, De Vernejoul MC, Boissier MC. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine. 2004;71:9-13. (Pubitemid 38183280)
32. Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y, Tanaka S, Kodama T, Akira S, Iwakura Y, Cua DJ, Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203:2673-2682. (Pubitemid 44833343)
33. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Glant TT. Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty. 1995;10:498-506.
34. Takei I, Takagi M, Ida H, Ogino T, Santavirta S, Konttinen YT. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints. J Rheumatol. 2000;27: 894-899. (Pubitemid 30389743)
35. Tanaka R, Yasunaga Y, Hisatome T, Yamasaki T, Iwamori H, Ochi M. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty. 2005;20:1049-1054. (Pubitemid 41820993)
36. Trindade MC, Schurman DJ, Maloney WJ, Goodman SB, Smith RL. G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 release in vitro. J Biomed Mater Res. 2000;51:360-368. (Pubitemid 30452138)
37. Warme BA, Epstein NJ, Trindade MC, Miyanishi K, Ma T, Saket RR, Regula D, Goodman SB, Smith RL. Proinflammatory mediator expression in a novel murine model of titaniumparticle- induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater. 2004;71:360-366. (Pubitemid 39463772)
38. Westacott CI, Taylor G, Atkins R, Elson C. Interleukin 1 alpha and beta production by cells isolated from membranes around aseptically loose total joint replacements. Ann Rheum Dis. 1992; 51:638-642.
39. Wong PK, Campbell IK, Egan PJ, Ernst M, Wicks IP. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum. 2003;48:1177-1189. (Pubitemid 36554516)
40. Xu JW, Konttinen YT, Lassus J, Natah S, Ceponis A, Solovieva S, Aspenberg P, Santavirta S. Tumor necrosis factor-alpha (TNFalpha) in loosening of total hip replacement (THR). Clin Exp Rheumatol. 1996;14:643-648. (Pubitemid 27013351)
41. Xu JW, Konttinen YT, Waris V, Pätiälä H, Sorsa T, Santavirta S. Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR). Clin Rheumatol. 1997;16:243-248. (Pubitemid 27273169)
42. Xu JW, Li TF, Partsch G, Ceponis A, Santavirta S, Konttinen YT. Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR). Scand J Rheumatol. 1998;27:363-367. (Pubitemid 28480227)